|

- 积分
- 3
- 威望
- 3
- 包包
- 20
|
2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸8 J& f: w: N8 K2 E2 o+ w ~
2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷! ~7 }! I/ L0 o5 e- K' ?+ ~ N. }$ Q' c
3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷5 B5 M$ X" M4 q
5-Aza:5-azacytidine,5-氮(杂)胞苷( G2 e9 S/ F3 L2 L; z) U- J
a2-PI:a2-antiplasmin, a2-纤溶酶原抑制物
0 I" _# ~% f$ V% r3 [9 |5 d; B& EAA:aplastic anemia,再生障碍性贫血
7 c. k( \! |/ T+ D, PAAV:adeno-associated virus,腺病毒相关病毒
' }8 X9 x+ K' g p0 cAb:antibody,抗体6 l4 n% H& H- u9 e
ABC:avidin-biiotin complex method, 亲和素生物素复合物法$ I' Z4 [; R+ s! h3 L* e4 {: O
ABMT:autologous bone marrow transplant,自体骨髓移植0 B6 B5 F) b9 I- T& y! I# W* K
Ac:accessory cell,辅佐细胞, ~# \# `# ~, _) U* [1 N
ACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖
q9 A) n; D% ~' y+ oACP:acid phosphatase,酸性磷酸梅+ R& U- Q7 p4 S+ g$ P. D3 N7 g. P+ ^
ACTD:actinomycin D,放线菌素D
& J2 I+ L. ?* |8 l5 e, XAcute:急性的
! V; j- Y2 R7 @ACV:cyclovir,阿昔洛韦' D* u! M* a& T) s1 Y
Ad:adenovirus,腺病毒( U3 r* J2 \2 D9 j
AD:antigen determinant,抗原决定簇
2 R2 j7 i) u7 ^6 R1 C- e i0 FADA:adenosine deaminase,腺苷脱氨酶. a' W {( u# y8 W$ L
ADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性) b$ M- C: {! d( w
Adjuvant therapy:辅助治疗
% \3 Y; C# i) O9 Y7 ~* ` J5 IAEL:acute erythrocytic leukemia,急性红白血病; ~& V% h M3 _. @' M# B5 l
AEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病
, D7 J: ^/ { QAFP:alpha fetoprotein,甲胎蛋白
0 w' u9 b2 T7 R8 f2 ^. I( w xAg:antigen,抗原: V. _+ ]3 {& j$ O( h7 h
aGVHD:acute graft versus host disease,急性移植物抗宿主病
2 _+ C; N6 Y8 l* LAid:anti-idiotype antibody,抗独特型抗体$ V- k1 p3 L5 ?. z" R* j
AidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征; p8 f, G9 j e% p
AIF:apoptosis-inducing factor,凋亡诱导因子/ W4 P8 m' H5 R/ G* c# z: j
AIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血
- {$ k( C0 M+ [8 g3 M3 oAL:acute leukemia, 急性白血病* Y. W& D* S3 ?4 B
ALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤
' G( n% [# a* }% C# ZALG:antilymphocyte globulin, 抗淋巴细胞球蛋白
. {% F0 C- {% ~! C3 v& DALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位
1 f: m; \& j- F( x1 CALL:acute lymphocytic leukemia,急性淋巴细胞白血病! U8 L; X' T& A
Allo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植
3 p$ Q- a+ S. W, D" _+ `( W4 `7 pAllo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植
% y& ]: v5 @( f4 j& ^Allogeneic:异基因的 " A/ [- H+ h6 j% ]' l/ O0 }3 j) b
Allograft:异体移植物 6 s" t* ?5 l x& s& {$ A
Alopecia:脱发/ m& s9 y8 K! j& C
ALP(AKP):Alkaline phosphatase,碱性磷酸酶. W9 E# ?$ G: I& W
AM:adhesion molecule,粘附分子
- k% z9 m1 a. _1 eAMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病
* E" n/ G( h" t4 U C2 }AML:acute myeloid leukemia,急性髓性白血病' }4 P- g$ L" l7 a
AMM:agnogenic myeloid metaplasia,特发性髓外化生
: {( x- _. a5 b2 }+ LANA:antinuclear antibody,抗核抗体
" ^9 B" c- i* l) M9 oAna-LL:anaplastic large cell lymphoma,大细胞淋巴瘤: A n( h" s8 U4 b$ b- {* Z
Anaphylaxis:过敏症3 ~, `/ S; h* L' f X1 q6 }
9 N0 P% y4 J9 h$ A! s0 J7 l, WANC:absolute neutrophil count,中性粒细胞绝对值
/ I1 o2 [; E& \4 QAnemia:贫血
. ?5 F: h6 A" O9 ]ANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病4 { k& S9 Y+ x% x; D
Antibiotic:抗生素;抗生的
/ A: G' d) Q# R% _Antiemetic:止吐剂,止吐药
& {6 U' a6 q. d6 l I0 T% Bantineoplastic drugs:抗肿瘤药物
3 L7 ]4 q9 K+ y8 J3 D. k- rAntisense:反义引物0 h( U4 G3 e% e/ A% A
APBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植
& ^2 h! S) h! y( }APC:antigen processing cell,抗原呈递细胞
% ~2 T0 ^7 ~) DApheresis:血浆分离置换法,血液成分部分清除
! X I+ L3 N2 Z3 Q1 V/ _; AAPL:acute promyelocytic leukemia,急性早幼粒细胞白血病4 e* w4 C8 v9 }6 u
Aplasia:发育不良,成形不完全
9 j3 B8 ^# y# pApoptosis:凋亡
& W, q- U5 [0 a8 i4 p8 x7 gAra-C:arabinosyl cytosine,aracytidine阿糖胞苷, Z1 y" O. U: s
ARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病! Z1 Y) P7 [" r; V
Ascites:腹水
2 x& n9 k3 V- @2 T# _ASCT:autologous stem cell transplantation,自体干细胞移植
! l& `8 D6 Q4 E- U0 AAspergillus:曲霉属
4 ], m; u" h# W: oASS:anterior superior spine,髂前上棘
5 e/ k( f6 t9 R# j: j2 g+ S WAT1257:nitrocaphane,消瘤芥1 a4 j5 ]: I1 Z, P/ i4 K
ATG:antithymocyte globulin,抗胸腺细胞球蛋白7 ]. D5 D. |# v; I( a
ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤 Z2 i4 `0 v- m: a9 t/ ~1 s# U
ATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征0 v; ^% P7 {7 j' T) {& d/ a4 C3 b
ATRA:all-transretinoic acid,全反式维甲酸) A' ?2 w& j) a; v& Z: D
AUL:acute undifferentiated cell leukemia,急性未分化细胞白血病, B4 E& c' x/ g" G4 g1 W
AuSCT: autologous stem cell transplantation,自体造血干细胞移植
6 `8 @ ^8 I) Y% U* ]Autologous:自体的
% }' U+ U3 j. k) z' @0 aAutograft:自体移植物
7 v$ i9 j4 }, X2 B4 R( D/ v' B! VAuto-BMT: autologous bone marrow transplantation,自体骨髓移植
" v" D# D; O2 w: B1 Iβ2-MG:β2-microglobulin,β2-微球蛋白+ q3 G2 V' J6 n6 P3 N
Back-up:备份) Z. T. K% ]2 y" Z" A
BCNU:Carmustine,卡氮芥,卡莫司汀( s- \9 g: |+ r* r( F
BCR:breakpoint cluster region,断裂点丛集区
. H2 i8 j; U JBFU-E: burst-forming unit-erythroid,早期红系集落生成细胞" z: Q$ G, K8 W% t
Biopsy:活检
+ |/ M/ A* C) N& A1 Y# x2 rBlast cell:原始血细胞,母细胞
+ h& h8 @) y; M9 XBlast-CFC:blast colony forming cell,原始细胞集落形成细胞! r- B8 J; y L8 q6 ]4 U- {
Blast crisis:原始细胞危象
7 W" y& s$ u7 MBm:memory B lymphocyte,记忆B淋巴细胞5 r4 r8 P8 p, I, b2 M& r5 U! |6 d
BMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病
3 E$ _. H, }+ o6 p( EBMT:bone marrow transplantation,骨髓移植, c/ K0 @! Z- |" j' ~
Bone marrow biopsy:骨髓活检
5 S$ Y* y+ N5 d, h# b' \Bone marrow puncture:骨髓穿刺
9 R: M/ `% ?7 Q& x1 C5 qBone marrow smear:骨髓穿刺涂片, l4 ~/ b# a& f- |, H w3 `
BRM:biological response modifier,生物应答调节剂: ]' i3 k4 _3 w# F
Bu:busulfan,白消安,马利兰
- i% B0 p# S5 q' h# V! d! H9 ~9 |Buffer:缓冲,缓冲剂,缓冲液
4 _: h5 r; N: l; U! [0 P# [+ Z* ]CALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原
9 F; h+ @/ X& `4 ZCAM:cell adhesion molecule,细胞粘附分子( m3 |5 ]" p$ e" [3 ~# I
Candida:念珠菌属,假丝酵母属
* F: K0 ^* u K |6 E. V6 m1 JCatheter:导管 1 `/ y! V6 L* O3 P/ ^3 q
CB:cord blood,脐带血
* P) c+ T9 e) b& g/ V) C7 ECB1348:chlorambucil:苯丁酸氮芥
9 C. ~* ~, A C; @- a' |' F' MCBC:complete blood count,全血细胞计数 6 ]0 L6 j2 D& z1 Q2 W# U6 w
CBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤
2 y. I! O, u; {CBSCT:cord blood stem cell transplantation,脐血干细胞移植# Y1 ~% T2 A* t, d9 X. E
CCI:corrected count increment,校正增值计数
2 w2 h& n5 @: {( rCCNSA:cell cycle non-specific agents,细胞周期非特异性药物
4 j2 R8 p6 L: R3 a. lCCNU:lomustine,洛莫司汀,环己亚硝脲4 V; L6 {0 n# B7 G2 O! {
CCR:continuous complete remission,持续完全缓解, \# Q8 @. W( z( {* `
CCSA:cell cycle specific agents,细胞周期特异性药物
8 r6 _# O" K/ p" w. i9 RCD:Castleman's disease,Castleman病
" S& |1 T' N" v+ I1 Y; {; |CD:cluster of differentiation,分化群$ v" R8 |% u d: _, O% i7 f
CD3AK:CD3 activated killer,CD3激活的杀伤细胞8 d$ L/ v# L1 l; p& c( ?! ^5 x" c
CDK:cyclin dependent protein kinase,周期素依赖蛋白激酶
) E# N# t, X1 ?CEA:carcinoembryonic antigen,癌胚抗原0 f; }7 t! {; C2 V" {
CEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病
6 {# h0 |0 i0 ~+ aCentral line:中心静脉导管,见central venous catheter. 9 N6 [+ @- q3 V" I7 h
Central venous catheter: 中心静脉导管,又叫做central line,Hickman catheter : U5 r, p+ L+ J- U
Centrifugation:离心; i( B, \) U) l
CFC:colony-forming cell,克隆形成细胞- @1 h; {; g" z. j* v
CFU:colony-forming unit,集落形成单位' d+ r1 J3 V, Q3 N
CFU-Blast:colony-forming unit-Blast,原始集落生成细胞3 m0 r) ~( R1 m& \8 f. `9 N
CFU-E:colony-forming unit-erythroid,红系集落生成细胞, {% t6 Y% \. S) W! R: m; _; _7 p( H
CFU-G:colony-forming unit-granulocyte,粒系集落生成细胞
9 ]0 B' c8 ]: P" E; P; gCFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞
; L: q3 T3 J( K0 D$ n4 pCFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位4 |3 o. e1 f& U/ ?; u2 b
CFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞
7 a. b" y4 K" ^$ g) x- T hCGD:chronic granulomatous disease,慢性肉芽肿病
) k3 K6 J% i& [CGP:circulating granulocyte pool,循环粒细胞池
$ Y5 `3 |5 X m P8 w7 ?! r; RcGVHD:chronic graft versus host disease,慢性移植物抗宿主病# s1 C, J* u& J' i: w0 I
Chemo-responsive:化疗敏感的 - C5 A m/ [, q+ l+ J' ~4 X
Chemotherapy:化学疗法 ' g# a0 F# q2 b. M; w: I b% t4 P* z
Chronic慢性的
! `8 [- k l$ f; N6 _4 ]8 VC.I.:continuous infusion,持续静脉点滴1 ?2 C5 ~( I8 ^/ g% _: U. u
CIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞& d" v! q4 {1 r( C: J* W
CliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统
; F3 z. p. N# M4 D2 t* tCLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病
/ n/ f6 b T# }" g' L+ pCML:chronic myelogenous leukemia,慢性粒细胞白血病/ t# ~& ^8 r' L/ E$ X% r/ I
CML-AP:CML-accelerated phase,慢性粒细胞白血病加速期
$ k: }/ b5 A4 l: g. CCML-BP:CML-blastic phase,慢性粒细胞白血病急变期* u5 w3 C4 E" w. _+ e7 q7 Z2 ^+ C% O
CML-CP:CML-chronic phase,慢性粒细胞白血病慢性期
. P) j2 H: @+ E" Y% L& TCMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病
; Y2 g. L/ Q( d7 bCMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病0 B$ |6 v8 H. V: B. R' l- p/ ?
CMV:cytomegalovirus,巨细胞病毒
$ ~$ f9 p- u6 F1 l6 L' mCNR:cytokine negative response cell,细胞因子不反应细胞
) q( N$ ^( z. k( x d0 M0 ^CNS:central nervous system,中枢神经系统
, i+ L" q! H3 o' F6 G' v2 xCNSL:central nervous system leukemia,中枢神经系统白血病. w% _+ H; c6 T' ?
Collection: 采集! `$ _, T# _$ b9 ?$ {7 r0 P4 z
Colony stimulating factor:集落刺激因子
' z* d3 e7 S! N0 M1 _8 y2 U6 Ec-onc:cellular oncogene,细胞癌基因
( r! h3 l/ F, d4 PConditioning:预处理
$ V Z6 ~$ e/ `$ f- x* J* h5 |Conjunctivitis:结膜炎
3 ~# R* v+ b& e" A, f: }+ u qConvalescence:恢复,恢复期
6 V! z# P- p( c0 V$ P9 dCP:cancer procoagulant,癌性促凝物质
$ r( `4 |, M3 J# A4 x- N: P. [CPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖
* d) R2 ?3 k5 b; `4 ECPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤
4 z+ ?6 ^1 A8 ^& W& }" A! x o' HCpmax:peak concentration,峰浓度( x6 u! h$ j& J; A
CPT:camptothecine,喜树碱, C. i& n$ `; K, F$ ~
CR:complete remission,完全缓解# ^* } X, j3 z% n& Q6 A8 J
CRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白
( Q1 v( v/ t) c) O" \+ T- ?2 gCRP:C reaction protein,丙反应蛋白 ; X" e5 C4 W3 v4 f6 [! a. ?
CRR:complete remission rate,完全缓解率8 {' z' M) |* D; i \; b$ c+ }9 m1 {
Cryopreservation:冷冻保存,深低温保藏
5 | D$ A4 ]& T1 J6 C, MCSF:colony stimulating factor,集落刺激因子9 Q; t% Y. v5 ?0 y4 u
CSF:cerebrospinal fluid,脑脊液
! O( O V- u# f6 Y& K- xCTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤
1 u( H! X1 f: v W4 L0 tCTCL:central T cell lymphoma,中枢T细胞淋巴瘤' G& e4 B( Z% }" |
CTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞
% g& e8 D6 F* ~: k/ j* }# ?. tCyclin:周期素
- P8 P5 D0 r5 e* Q8 l4 D9 uCytomegalovirus:巨细胞病毒 1 ]) J0 ~% ^) j, d3 r$ A
DC:dendric cell,树突细胞
- J" E, J! f; {4 M% jD-D:D dimer,D-二聚体8 z# M' R7 Q+ p2 G
Del:deletion,缺失! y* X$ Z* o3 ~
Dermatitis:皮炎 8 ~% U# e7 r7 r6 \) N' j! t0 i
De nova AML:非继发性急性髓性白血病
7 c: b; |- G9 V% A4 D" \DFS:disease free survival,无病生存期. ~. U7 h. Q4 @2 w' k* ~+ s
DI:DNA index,DNA 指数- N8 F, ]6 B( W
DIC:disseminated intravascular coagulation,播散性血管内凝血! | ?. s' h' D7 d9 E
Dilution:稀释7 U3 O( b; _0 W- ]
DL:discordant lymphoma,混杂型淋巴瘤
( D: z/ Z0 y" L: c0 K' DDonor:供者( ?4 V+ c6 M! s% A
Dysplasia:发育不良,发育异常 * f0 B' t, E' V! ]8 u& I0 D
EBV:Epstein-Barr virus,EB病毒+ Q' z# A% k% \8 S! ~( k# Y( O
ECM:extracellular matrix,细胞外基质
! r. h) Q% q4 ?' a: t: ]-ectomy:(后缀)(外科)切除,除去,去掉 , }; D8 D- c W& x M" I
Edema:水肿
- r. [1 F# B" K5 S9 ]* Q7 UEGF:epithelial growth factor,表皮生长因子# b3 r- c- T0 V3 _0 u! s- ?6 C
-emia:(后缀)血液疾病 - h+ v! n! V! b" G8 p7 z
Encephalopathy:脑病 , u( S k) S; f" c% K& F( H
Encode: 编码
4 U( ?1 e- Z7 c( L+ I" P, Y" hEngraftment:移植物植入 5 k" X/ f# S6 `% i. u9 i1 W2 e
Enrich:富集2 C; q, R3 G- t- B. v7 Y
Enzyme:酶
( K5 x/ ^4 D1 ?6 r( JEosinophil:嗜酸性粒细胞# L7 \8 B) ^1 P, h3 Q
EPO:erythropoietin,促红素,红细胞生成素
* U% W, _' Z& h$ n+ }& P4 FETT:essential thrombocythemia,原发性血小板增多症1 W3 f, W1 P( K0 P l
Ex vivo:体外 0 H1 p- \0 l H5 V% u/ J
FACS:fluorescence activated cell sorting,荧光活化细胞分选系统& G' ?7 n C# x% H: U- G
FCM:flow cytometry,流式细胞分析技术
/ L& ~! P; J9 U- e- r: yFDC:follicular dendritic cells,滤泡树突状细胞
. r, @. p8 V& N5 Z4 g* i( jFDGF:fibroblast derived growth factor,成纤维细胞源生长因子 . a6 X/ Y# k4 G. t t0 W. Q/ D4 J9 j
Febrile:发热的 # w. k1 D2 _1 b6 M, I' x. r2 n' A
FFP:fresh frozen plasma,新鲜冰冻血浆4 G% Y, H" X" |) a, W) H- s! p
FGF:fibroblast growth factor,成纤维细胞生长因子/ g# z* ]" S% p V3 d0 p* o5 J: Y8 y
FHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症- s) d h( D9 F1 |# f
FISH:fluorescence in situ hybridization,荧光原位杂交& e5 E2 j' a6 X) {3 F
FMF:familial Mediteranean fever,家族性地中海热
. N( k1 {/ ]; HFoley catheter:弗利氏导尿管,气囊导尿管 3 r2 @+ d2 p( v' R+ O
FrTBI:fractional total body irradiation,分次全身照射
- C2 e& K g# H G( W3 I+ R7 XFSRC: 胎羊体内增殖的人造血干细胞& n: Q% R9 k8 ]- G$ C H8 x# T- I# O5 N
Fungus:真菌 / Q9 o |1 _, c7 G! w
Fungi: Fungus复数形式
" p* M% G M$ X, PG6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶
; Y, z$ ^+ Z; V" k4 R% Y/ OGastritis:胃炎
% R q0 [9 H' c% p0 F+ |Gastrointestinal:胃肠道的
4 a$ O; r8 Y9 W+ f- y( l/ I5 PG-CFC:granulocyte colony forming cells,粒细胞集落形成细胞4 c1 T- ? ^8 S( @
G-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子
* q5 R! J' n* R( b+ UGCV:cytomegalovirus,巨细胞病毒
2 j" G- o/ X4 i% K8 d$ {- jGCV:ganciclovir,更昔洛韦8 O* j2 l) t! b
GI:gastrointestinal,胃肠道的0 Z' g0 G: ?. I% x/ G5 g0 Y
GM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子 & P( u M8 F+ z6 E5 t
GM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞; _3 s9 f% b1 Z; ]
Graft rejection:移植排斥(反应)
# B$ S; X, j( ~$ z6 WGraft-versus-host disease:移植物抗宿主病
9 ~; [+ R" F7 O3 d2 cGranulocyte:粒细胞 9 O3 V7 p' b1 s9 x
Growth factor:生长因子 4 F' Y7 p; ?! m! T; j. B( m
GTR:granulocyte turnover rate,粒细胞转换率
* ^1 A, F6 ?0 u4 y7 @GVHD:graft-versus-host disease,移植物抗宿主病 2 V- v4 j# q4 ^1 |1 ^' n6 h" L
GVHR: graft-versus-host reaction,移植物抗宿主反应. O2 d- S1 o5 t) |( [
GVL:graft-versus-leukemia,移植物抗白血病5 ]1 S* S, e$ Y: s: L+ `9 \2 l
GVT:graft-versus-tumor,移植物抗肿瘤$ k7 N9 C9 U+ w) |; H8 ]* n j
Haploidentical: 半相和的) x7 S3 E& s( ~9 b! J( I
Harvest: 收集,采集: I' a: S; _5 R1 g
HC:hemorrhagic cystitis,出血性膀胱炎$ ^ x6 D' }; { X
HCL:hairy cell leukemia,毛细胞白血病
6 R# G' X( X* ]: f# c* YHD:Hodgkin's disease,霍奇金病) `" b5 \; V; {0 q0 G# f3 e: D5 ]
HD:high dose,大剂量. u4 [! g# V9 z6 r6 u# M' v
Hematocrit:红细胞压积 5 c* m. I( U2 H8 C% O# N" i5 i. M! s
Hematology:血液学
' R2 }2 l% f" }- o4 Q( Q4 SHematopoiesis:造血作用,生血作用2 S6 H) O$ R# C3 n% X3 B% ~/ i v
Hematopoietic system:造血系统
& ^6 L4 k/ K. l% o5 j1 ~2 U( X2 pHemoglobin:血色素,血红蛋白
; x, b: j/ ^5 L1 WHemorrhage:出血 1 E; _. ~! G% ~! Q; }& T( c1 ^
Hemorrhagic cystitis:出血性膀胱炎
2 b1 s! q$ z6 Y# J4 qHepat - :(前缀)肝的$ p0 J1 W9 g# a- M* a1 Q4 \
Hepatitis:肝炎
& G/ T0 F& r" K: {HES:hypereosinophilic syndrome,高嗜酸粒细胞综合征$ k& O2 v& M& K% {
HGF:hematopoietic growth factor,造血生长因子
( \* W' x$ t2 a4 tHHV:human herpus virus,人疱疹病毒; ~) |5 ^$ ^2 A9 x. y
Hickman catheter:Hichman导管,中心静脉插管 & W% J+ H/ J( k8 \
HIV:human immune deficiency virus,人免疫缺陷病毒
% i0 j4 T0 G& G$ d* fHLA:human leukocyte antigen,人类白细胞抗原 4 i6 H3 T& l- c/ V1 {) {! N
HLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症8 ^; K# ^' n7 I# f) ~0 N5 M6 G) i
HMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症
7 S( q% A" l! u! k6 M: I8 K: rHomogenic transplantation:同基因移植/ j. M3 V' N, V3 B4 K; V
Homozygote:纯合子
7 X7 G6 ]7 B7 b* WHPC:hematopoietic progenitor cell,造血祖细胞* O) n, R8 }8 K0 s5 x
HPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位( K% t# L. `' l" s6 p
HR-ALL:high risk ALL,高危型急性淋巴细胞白血病
; ]8 N3 A A, K2 sHSC:Hand-Schuller-Christian disease,韩-薛-柯病
1 s2 `! t$ {* E5 A8 @+ PHSC:hematopoietic stem cell,造血干细胞
& Z: K" A' q L8 h2 n+ W. d$ eHSR:homogenously staining region,均染色区$ J& W9 N# W: E, q- F5 g- L
HSV:herpes simplex virus,单纯疱疹病毒
6 u [. x1 |" R7 h" P1 H1 v' a: `HTC: typing cell,纯合子分型细胞
% s/ K; R) t: s% Z. NHTLV:human T cell leukemia virus,人类T细胞白血病病毒
+ U- Z+ j& v5 N! hHVOD:hepatic venous occlusive disease,肝静脉闭塞病+ L7 k: U, |! S5 u9 y
Hyper- :(前缀)高,超,(过)多% a! u3 c6 h. R( r, e' K
Hyperalimentation:高营养支持,静脉高营养 C" {% L+ ?# V/ C
Hyperpigmentation:色素沉着过度 , V" f8 W$ X; S& A. Q- z
Hypertension:高血压
+ ` M W9 O0 ^- Q+ e dHypo- :(前缀)(过)低,少于8 I$ ^! } J" h( w5 D; s
Hypotension:低血压0 ~! j, {9 x0 H3 N" S: G, Y
IAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征: h7 U: ~/ _: v* d" E d
id:medium dose,中剂量
+ q4 N8 D: F Kid:initial dose,初始剂量
: E- I/ P/ F# a4 \% J/ ~% WIF:involved field,累及野 l% J8 l8 [- [& e
IFN:interferon,干扰素
( f- ?$ P% y# _% L' u" Q IIg:immunoglobulin,免疫球蛋白 ) S" w- [3 i# m0 b3 e; T) K, \( r
IGFs: insulin-like growth factor,胰岛素样生长因子
0 f T9 D: e" \/ wIgH:immunoglobulin heavy chain,免疫球蛋白重链4 Z8 ~4 a1 b0 z7 r$ |0 i
IL:interleukin,白细胞介素' `8 i7 a/ X( X& s! w6 E' n! P
Iliac crest:髂嵴
5 D2 B& _/ z% e' mI.M.:intramuscular,肌肉注射
- @3 o# v$ t% b& b1 F3 i0 pImmune system:免疫系统 : T& W: H+ B3 y+ C
Immunocompromised:免疫受损的
* s/ y/ B% r8 F- r( mImmunoglobulin:免疫球蛋白 # q+ j3 n6 A2 F9 G4 i6 o9 B* t1 V
Immunological tolerance:免疫耐受
9 {$ J" z) ~1 T) R7 e1 bImmunosuppression:免疫抑制 ( s/ _% K; ^2 V' _2 }
Incubation:孵育
- H3 y3 n# V0 F$ Y7 o: d; E. jinformed-consent:知情同意2 @' o8 a# c8 R) _7 C
Intravenous:静脉内的; Q% i4 E, v0 Q" B
inv: inversion,倒位* ~' j: S% J# x; `7 @3 y- d/ F
in vitro: 体外,离体5 J! t) R$ n) i- B O. N5 d2 H" U
in vivo: 体内
0 S+ G, C5 z8 a6 W& X0 F1 G3 P- j6 dIP:interstitial pneumonia,间质性肺炎
& w k! \, K) mIsolation: 分离
" o* Y7 U1 l$ c s% L& m0 h) ~I.T.:intrathecal injection,鞘内注射8 g. i7 V- A( p( ?) { C
-itis:(后缀)炎症
5 J% h2 ^/ g! E+ m/ Y6 d$ y2 zITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜$ _9 v/ Q% u8 U; b$ X
Jaundice:黄疸" U* e+ x. c! e9 Z) v
KPS:Karnofsky score, Karnofsky评分
- D2 D% c* s ^# t6 \LAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)8 _/ M/ }! T7 I9 y9 ~: b6 W+ R c
Laminar air flow unit:层流间 0 G' B( C& x- B, I8 L& z
LCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症
B5 y8 b1 |! I c* T' R$ ILD:lymphocyte depletion,淋巴细胞消减型8 u/ F* z9 V: A. ~; o. {! f
LD:low dose,小剂量0 [" `/ }; P7 g- Y( c
LDH:lactate dehydrogenase,乳酸脱氢酶
7 D1 x7 }0 C+ m3 ?+ ~) [! {. NLeukapheresis: 白细胞采集物1 m4 Y7 D' z% H6 Q
Leukemia:白血病 $ ~- D. G5 N, r) t& a
Leukocyte:白细胞$ }! B6 z% X2 K7 y' K1 Q' t# ^1 N
Leukopenia: 白细胞减少症+ D, j9 h. M% x9 i. R, b
LFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原 ! K9 p" a, Q! R: {
LFS:leukemia free survival,无白血病存活期3 B! J/ C- B1 j: W3 f
LGL:low grade lymphoma,低度恶性淋巴瘤
9 y. t2 ~: ]7 u7 U1 J; K. R _LHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体
( G4 x, G5 r* M/ h4 C3 g& DLI:labeling index,标记指数
$ B: Q) ? o2 m9 V% E; TLIF:leukemia inhibition factor,白血病抑制因子1 W" p- K0 q& R: @0 Y( L
Lineage:系1 B1 j5 ^$ i) r: f: ~7 k6 g4 d
LOH:loss of heterozygosity,杂合性丢失
$ G3 j2 l% {4 N" z e8 g9 ELP:lymphocyte predominance,淋巴细胞为主型, V6 b& G# n+ n: ]. j
LRP:lung resistance related protein,肺抗性相关蛋白
2 N( E; ^0 k, l' e# A0 v" ?LTB:life-threatening bleeding,致命性出血
7 Y9 m7 r1 j5 u5 I$ rLTC-IC:long-term culture-initiating cell,长期培养起始细胞; M5 g1 w7 l9 D
LTR:long terminal repeat:长末端重复序列
3 d- o, c3 B( [& G: j" F# ELVL:large volume leukapheresis,大容量白细胞单采
" M# B {* h1 Q( J3 U1 }Lymphocyte: 淋巴细胞
$ s5 N2 ~* t9 N' v1 ^* I" SMacrophage:巨噬细胞+ X" h$ _, ]5 P2 m' J4 T
MACS:magnetic activated cell sorting,磁性活化细胞分选4 C1 J0 a. m9 D d
MAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞)
& I' w5 S3 K+ E& M) [1 O$ AMalabsorption:吸收障碍
0 \6 w4 J- Z1 E! k8 P4 l$ y% cMALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷; g6 k6 ^& _+ i% e& ]/ @# M
Matching:配型
* N: c2 R5 f% o" c4 s1 p0 WMBDI:marrow blast decline index骨髓原始细胞减少指数
; D" a! O8 M( ]MC:mixed cellularity,混合细胞型
% m1 y9 b; X3 F fMcAb:monoclonal antibody,单克隆抗体
3 }4 T/ ~5 R) p- kmCR: median complete remission,中位完全缓解
- H" x1 n" o/ [5 Z% {8 iMDR:multiple drug resistance,多药耐药
Q; C$ p6 ?. N* @MDS:myelodysplastic syndrome,骨髓增生异常综合征7 h9 W$ B A$ P/ K# M
Megakaryocyte:巨核细胞& T6 E5 m a& O
Metabolite:代谢物 # K F& V/ |& T8 k6 \' D3 p
Metastatic:转移的 , O4 ^7 |/ Y5 v" F
MF:myelofibrosis,骨髓纤维化
0 {' n! t) x" L& v* T( LMF:mycosis fungoides,蕈样霉菌病
5 E# e4 q7 Y$ h& \7 P/ A) g! s# P, R1 fMGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子
6 X/ O7 X& H# aMGP:marginal granulocyte pool,边缘粒细胞池
: Y6 j# E, L- f" s* W, NMGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症
7 Q. U9 o1 Y4 h: H3 rMH:malignant histocytosis,恶性组织细胞增生症. ?9 H1 I$ Y/ k, }- f S+ `
MHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统
1 Q" m8 k6 U5 W' E6 NMHC:major histocompatibility complex,主要组织相容性抗原复合体/ ^) u) J# ~. p" j6 l
MLC:mixed lymphocyte culture,混合淋巴细胞培养 ( m3 H, u# t h
MLL:mixed lineage leukemia,混合系白血病! }/ Y/ C$ a# C) D/ g9 T" @# r
MM:multiple myeloma,多发性骨髓瘤0 N5 e# i0 O: [. t1 R9 c
MNC:mononuclear cells,单个核细胞
2 y, Q+ N3 n" d- p9 HMobilization:动员: N9 p, C8 _$ T- t2 p
Monoclonal antibody:单克隆抗体
9 C. }. s2 `1 W; PMonocyte:单核细胞
8 f+ m0 `5 o: q, ]0 AMonozygotic:单合子的) u# |: u- M! D$ c% g' v
Morbidity:发病率
* X& T% Z, [) IMPD:myeloproliferative disease, 骨髓增殖性疾病
w' C2 B$ O% {0 T1 A% E X. P" DMPO:myeloperoxidase,髓过氧化物酶
7 s: W( |$ w* E6 GMRD:minimal residual disease,微小残留病变 " t0 k* L1 Q8 A% Z, I1 @
MRP:multidrug resistance-associated protein,多药耐药相关蛋白
) l' W2 ?6 \ P0 _Mucositis:粘膜炎
: ]) o% }8 ?$ a5 b& |6 g, K4 SMUD:matched unrelated donor,非血缘关系配型相合供体
6 o; n$ T; N# N3 h) T9 LNAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶* q: D* G) |7 d$ r; ~7 I
NB:neuroblastoma,神经母细胞瘤' m, J) Z, n- \4 ^
NBM:normal bone marrow,正常骨髓2 i3 Z, _' ]/ Z% p3 }
Negative selection:阴性选择
" e8 O* X6 A) P( p7 `Neuro- :(前缀)神经的
' G9 N1 z% a- F& ^# R) GNeutropenia:中性粒细胞减少症 9 N! @/ O& K/ Q0 ~
Neutrophil:中性粒细胞 6 c1 _ _& s* o9 K# T1 n
NG:neutrophil granulocyte,中性粒细胞
6 Q/ H8 `& m4 Y# H+ P9 {: NNGF:nerve growth factor, 神经生长因子
6 M$ {' c6 C" D- X4 p# I* ZNHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤
# H8 H, E$ ?- c) O! xNK: nature killer cell,自然杀伤细胞+ I; y7 `+ k3 h( \0 R% g7 z H
Nonmyeloablative transplantation: 非清髓性移植0 e1 K* _7 k# ~; b5 H& w
NPO:不能进食 1 y" e P! @6 w( ]! `
NS:nodular sclerosis,结节硬化型 ; v9 q, i1 v! m3 k( m# \5 F- Q
Oncology:肿瘤学 & }' j$ `2 N, I4 {" e- v+ @1 _
Oto- :(前缀)耳的0 ~8 m2 i3 M7 Y/ q9 C0 b0 X+ v
PA:plasminogen activator,纤溶酶原激活物
0 ~; I$ z: ?- E2 W* h7 O, oPacked red blood cells: 压积红细胞 + _5 l: s+ I% `" u7 N$ u
PAE:post antibiotic effects,抗生素后续作用
7 L8 u/ |+ ~2 b( W5 M# C, K& S- aPAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂0 I. _( t' |. }8 j( z
Palliative:减轻的,缓解的
9 d+ @! Q3 H9 ]5 q+ X9 [palliative care unit (PCU):终末期病房,临终关怀病房6 K2 M4 L7 Q3 D1 Y) e& ?- [
Pancytopenia:全血细胞减少症 h$ M) j# h: N' y( M
-pathy:(后缀)病 9 y0 t7 U. ?3 X/ s; `
PB:peripheral blood, 外周血
( V8 K) g0 f0 q( C2 W. o3 KPBL:peripheral blood lymphocyte,外周血淋巴细胞; H( w; C( @; |( j. _: D0 y+ Y% ~
PBPC:peripheral blood progenitor cell,外周血祖细胞
j% T- C; n. ~- l9 g5 K' }PBSCT:peripheral blood stem cell transplantation,外周血干细胞移植* X% S' Z0 O' p& P+ X! @5 Q# i
PCA:procoagulant activity,促凝活性物质
o' d) O6 A3 A8 t$ [. yPCD:programmed cell death,细胞程序化死亡7 ~9 o6 k4 D! F0 O4 ^
PCL:plasma cell leukemia,浆细胞白血病, h. K+ Y5 c/ S& {/ d' |7 n" s
PCLI:plasma cell label index,浆细胞标记指数6 B; @, @/ r; ^
PCR:polymerase chain reaction, 多聚酶链反应
( k7 {/ F) a, F# vPCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析% p5 _$ _) w2 A# |: \# _% ?
PCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交6 I* Z7 O9 X [4 k
PDD:percentage depth dosage,百分深度剂量
0 O& A4 Z8 H9 w' a) VPDGF:platelet derived growth factor,血小板衍生生长因子
7 `2 _" ?6 D, r8 w8 N& U0 Q3 PPDR:primary drug resistance,原药耐药4 z) u1 J1 N }/ i; B
PE:plasma exchange,血浆置换
& |$ e1 N$ h, D( L- Y-penia:(后缀)缺乏,不足
, c* K$ y! t$ U* o' XPeripheral neuropathy:周围神经病变
2 v4 M5 T+ y& a- gPetechiae:瘀点,瘀斑 U& B9 T6 D+ N1 e
Pfu: plaque forming unit,空斑形成单位
4 f+ k+ m- \- |' ]2 {4 M0 S l {PHA:phytahematoagglutinin,植物血凝素
( I, Y$ e; Q% A0 cPhlebitis:静脉炎 0 x3 t/ W+ [9 r8 h+ j( f( j h8 `, ?
PHSC:pluripotential hematopoietic stem cell,多能造血干细胞
# ]' d1 s! P: Z7 o-plasia:(后缀)发展,形成
/ L" B7 U- k% y# \/ V1 W6 Y7 g! IPlasma:血浆: L2 H# w, j, Y/ c: j3 X! C
Plasma cell: 浆细胞
1 Z5 d5 M; k5 x0 l# b, nPlatelet:血小板
" d" m1 Y% l9 W9 p6 F: r" }) U0 {PLG:plasminogen,纤溶酶原
& f/ T0 u8 U" z2 @PLL:prolymphocytic leukemia,幼淋巴细胞白血病0 V- q* @: H& P5 S# n. x
PLT:platelet,血小板
! F3 ~' x1 s3 K% P) b* } Y2 ePLT:primed lymphocyte test,预致敏淋巴细胞试验1 V( U% D6 l: r6 g: b2 ~
PMN:polymorphonuclear leukocyte,多形核白细胞: Y7 v- G5 l9 _! i8 g
PNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷
8 a& c q6 O. I4 Y7 bPNRE:p53 negative response element,p53阴性反应元件" b5 \. n! D" q: `( G
POD:PML oncogenic domain,PML癌基因结构域
( ~5 [. U# p' `( K9 X% nPolycythemia:红细胞增多症
7 K+ H! S; |: q3 j! ePositive selection:阳性选择! e Y8 }4 _: d4 D' N. j
PPSC: pluripotent hemotopoietic stem cell,全能造血干细胞/ t( k7 a% l. p% ^: a/ z% ~
Preparative regimen:预处理方案
! d: e4 k% g6 j$ N0 I7 {, L8 I, EProgenitor:前体,祖先
0 ?! b1 x9 N, o4 ePrognosis:预后 9 S% F+ o" P/ x3 S& Y, L% c% L! W
Prophylactic:adj.预防的;n. 预防性,预防药1 [& ]7 X1 Q& g. t4 d; Q
Prophylaxis:预防法,预防
1 H, b) I* F }Protocol:草案,协议,治疗方案
3 x: g& d" n6 E6 eProto-onc: proto-oncogene,原癌基因! W5 \! O6 l7 c+ c$ o+ E
PSS:posterior superior spine,髂后上棘+ n% ~8 L; g1 j
PT:prothrombin time,凝血酶原时间% U7 {& l" x8 C) m) f
PTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤
# n2 d2 x3 q0 V% v: kPTH:post-transfusion hepatitis, 输血后肝炎4 ]# x1 L1 ^7 u! |
Pulmonary:肺的
, t9 k: y) ?1 _8 S( i/ _9 e* r' a/ YPurging:净化: v' I& j0 e3 x4 D5 Y% `9 T4 ~* e
Purity:纯度0 X+ k! |& V* Z! c! r
PV:polycythemia vera,真性红细胞增多症
7 i8 ?( C8 c; S5 CQuality of Life (QOL):生活质量
2 T, q- x, ^+ oRA:refractory anemia,难治性贫血
% c3 h3 l9 V; E! mRAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型
8 o# |8 Q; ]3 ?" Y" [) }RAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型
' h, u% b$ c/ k4 LRAR:retinoic acid receptor,维甲酸受体) _: b+ |$ g) d. C* H+ o' V/ Y/ ?
RAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多2 p1 x( v1 s5 f2 R
RAS:retinoic acid syndrome,维甲酸综合征- U& ^% L6 N/ o9 P6 ^6 K6 N* Q
RB:retinoblastoma,视网膜母细胞瘤
( X9 K8 X( @% `/ U A% J: \RBC: red blood cell,红细胞
5 P+ [5 U0 f9 x$ I3 |" w, @Reagent:试剂+ S( [* a) K7 E4 }2 v* V
Recipient:受者
- t1 ]) O& u) w# wRejection:排斥
+ S# q0 q/ ^- T3 P7 N% x" X2 ]Relapse:复发 ) Q! e% h" y4 G" \$ {7 {+ i# b% Q& i
Remission:缓解
# a: f1 O. B) o' BRenal:肾脏的,肾的
9 J# X1 b4 ^# ^ M6 TRFS:replase free survival,无复发生存
4 |( Y" o) x1 A7 O2 R) LRPC:radiation protective competence, 辐射保护能力- I9 G! G9 ^3 F) r6 {' l% _
Regimen-related toxicity (RRT):预处理相关毒性5 E* V. _& i* ]5 P/ R+ Z3 j2 k( v
RT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应( d# Q6 h6 E- d1 w! [6 x) Y" X
SBB:sudan black B,苏丹黑B
7 s2 h+ @& U# M" a6 nSCE:sister chromatial exchange,姐妹染色单体交换
; |- L. ~( }, \0 p3 P6 MSCF:stem cell factor,干细胞因子
) {; R1 p. L' U7 K4 X$ r9 g4 q" @SCid:severe combined immunodeficiency disease,重症联合免疫缺陷, U# f1 k+ s8 E& U
SCL:stem cell leukemia,干细胞白血病5 o/ a ^5 e/ Z) w* v
SE:specific estarase,特异性酯酶
' X# F6 `! d3 w" O# w% g: pSelectin:选择素8 w! @ ?# s- | |" a
Sense primer:同义引物
3 ^: [" ~5 V8 [% i5 KSeparation:(细胞)分选 Q3 a- x9 B, q0 A7 q0 B2 U
Sepsis:脓血病,败血病
- T1 [! C, W6 _5 ~Sequencing测序2 g( ~1 A' ] E4 }$ W$ ]
SF:serum ferritin,血清铁蛋白
% A$ I {6 U# r: p' aSHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大% m* @0 O: s* m( Q5 w, E2 D
SIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法% {* ^/ C6 z/ {$ o" a- \
SLE:systemic lupus erythematosus,系统性红斑狼疮
7 A& y/ d6 `5 Y. S& R% k7 P5 V3 jSLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤
5 @+ P0 O) X4 Q3 ~% ASolid tumor:实体瘤$ t# k0 c3 w0 K9 Q: d5 l: d$ N
SR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病7 E7 h7 G! J4 z' N
SRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞# s7 O, K( f7 K0 ]+ T% P: V$ F2 _ M
SS:Sezary syndrome,Sezary综合征 & E! t; {6 y& s" W
Stem cell:干细胞; z/ a/ X( C2 [& b4 g6 {
STNI:subtotal nodal irradiation,次全淋巴结照射 ; ]+ d! \) e; v
Stomatitis:口炎
3 T0 A4 m! b% G( D( Y9 X% FSubclavian catheter:锁骨下导管
. Z# i0 @" d: Y5 _* n3 n# h6 jSupernatant:上清( r" [, m& @ K% j0 W# I
Syn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植 % p; I L& q" X/ E/ n9 O. F8 ~
Syngeneic:同基因的
5 l+ H0 y+ u6 g; G7 U6 M+ I) HTAM:tumor associated macrophage,肿瘤相关巨噬细胞
/ F- C$ F& S& q0 L5 mt-AML:treatment associated AML,治疗相关的急性髓性白血病8 `) d; S: C" {& h; Y
TA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病5 e9 P9 a5 ?+ N$ g; g: Z
TAA:tumor associated antigen,肿瘤相关抗原
4 O* p* N1 M7 f6 KTBGP:total blood granulocyte pool,总血液粒细胞池
! S; Z5 P4 E) kTBI:total body irradiation,全身照射
) k0 y# y& X" A; qTc:time of cell cycle, 细胞周期时间
- F; R( ]" c+ }# I3 T MTCD:T cell depletion, T细胞去除$ C; a+ \, Y0 h
TCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤
5 O; i4 ?( Y; dTCR:T cell receptor,T细胞受体
- e, e8 ~' \; d& z9 L4 uTCS:tumor cell survival,肿瘤细胞成活
0 Z+ X" y) a$ _8 [TEN:total enteral nutrition,完全胃肠内营养( y2 {9 {' Z( U1 ~
TF:tissue factor,组织因子
c- \6 y+ ?: C" D% _8 iTF:thymic factor,胸腺因子/ n- n% N) P3 v0 o
TFPI:tissue factor pathway inhibitor,组织因子途径抑制物2 f4 {9 z+ X5 L
TGF:therapeutic gain factor,治疗获得系数3 u# K( k: g' n: i0 N% G- F! \
TGF-β:transforming growth factor-β,转化生长因子β$ @: L# Q X3 k! K( f
Thrombocyte:血小板 " A- O2 N- e9 j+ }9 U4 y6 @' w
Thrombocytopenia:血小板减少症
6 M8 J7 a I+ K- @) x% r. KTIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞) [; `( U) ~1 w5 e
TL:testis leukemia睾丸白血病
/ p' t. L( T' n( N3 V& t& F, kTLI:total Lymphoid irradiation,全淋巴照射6 I( }& T9 I& i
Thrombotic microangiopathy (TMA):血栓性微血管病! Y7 L0 J0 s: t( B8 w3 K
TNF:tumor necrosis factor,肿瘤坏死因子7 X; r0 u+ \+ W; y
TNI:total nodal irradiation,全淋巴结照射6 R$ A' t# G; D, V
TOPO II:topoisomerase II,拓扑易构酶II
" [% l' d+ D& GToxin:毒素
/ W/ H/ a9 q$ T9 yTpdt:potential doubling time,倍增时间
" K0 u5 m4 ^: GT-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病8 c# M; o- C$ S$ ?" N- `& u. p
TPN:total parenteral nutrition,全肠道外营养,静脉高营养
" m( [/ G: ^4 s: hTPO:thrombopoietin,促血小板生成素
0 q( c: {9 K( s# m" ]& [1 U! i4 eTPS:treatment planning system,治疗计划系统; ^4 R8 _# v$ W' [/ Z7 l
Translocation:易位' O: ]( j8 g4 X& C* x
Trauma:创伤
2 l' h1 @: m; [- ATRM:transplantation related mortality,移植相关死亡率
* G8 ^: t- ^. C- v, ~TSC:timed-sequential chemotherapy,时相序贯化疗" `+ Q, F; a# y# z4 L( K
TSPA:triophosphoramide,噻替派
4 T9 Z* d0 P) e' g4 ~- N+ LTTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜! q9 J( f+ f( ?- j. X
Tumor:肿瘤
8 o- x+ F4 d. _2 [. STumor burden:肿瘤负荷
t, s6 b. u6 H9 v5 @3 U; q9 NUCB:umbilical cord blood,脐带血- l6 H2 Q8 C9 [( q$ S; F
Ultrasound:超声
7 h$ u R' E" P1 `' R ~7 L3 a/ s9 QUmbilical cord:脐带' g; _/ Q7 g* @% E5 L: F
VAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征
% ], _# H" |) ^/ Y& ?0 kVGPR:very good partial remission,非常良好的部分缓解" _; Q. J6 w2 A
Viability:活性+ c* V1 f/ s, f0 Z, ?) R1 g; ^
Virus:病毒 - _! [1 b1 o0 S! R, O" M7 U
VOD:veno-occlusive disease,静脉阻塞性疾病
3 V+ B2 r8 t3 U0 u M6 m+ r* z3 Sv-onc: virus oncogene,病毒癌基因
) I. v. Y Z' I5 R' CVPF: vascular permeability factor,血管渗透因子& L; o+ {* y. G2 ~. r$ _' ^" I
VZV:varicella zoster virus,水痘带状疱疹病毒- {; A0 ^: |/ X9 O& U4 G2 X
WBC:white blood cell,白细胞 $ p4 F4 V2 n. L; p
Whole blood:全血
) D9 z2 T6 s1 E8 d0 }$ R( j# iWT:Wilms tumor,肾母细胞瘤! A0 T2 v: W& P( ?: f
Xerostomia:口腔干燥症 : S3 k! i# d& _) \& t& \
Yield:产量 |
|